Alexandre Calon

5PUBLICATIONS
33CO-AUTHORS
Predictive and prognostic markersTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 14, 2026
Stromal biomarker-based framework for identifying pMMR/MSS and dMMR/MSI colorectal cancers with poor outcomes and limited benefit from immunotherapy.

Mar Iglesias Coma, Jordi Badia-Ramentol, Carolina Martinez-Ciarpaglini

|Feb 03, 2025
Micro Immune Response On-chip (MIRO) models the tumour-stroma interface for immunotherapy testing.

Alice Perucca, Andrea Gómez Llonín, Oriol Mañé Benach

|Feb 22, 2023
Peptide-Platinum(IV) Conjugation Minimizes the Negative Impact of Current Anticancer Chemotherapy on Nonmalignant Cells.

Jenniffer Linares, Monica Varese, Anna Sallent-Aragay

|Feb 10, 2023
Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy.

Jenniffer Linares, Anna Sallent-Aragay, Jordi Badia-Ramentol

|Sep 09, 2022
Targeted immunotherapy against distinct cancer-associated fibroblasts overcomes treatment resistance in refractory HER2+ breast tumors.

Elisa I Rivas, Jenniffer Linares, Melissa Zwick

Pageof 1

Frequent Collaborators

2 joint publications

Roger R Gomis

2 joint publications

Andres Cervantes

2 joint publications

Jorge Pisonero

1 joint publications

Anna Lladó